Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,601,961
+$17,288,530 QoQ
Shares Held
15,509
+986.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.57%
of 13F equity value
Holder Rank
#917
of 4,605 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ramirez Asset Management, Inc. holds $30,805,111 across 7 Drug Manufacturers - General names. LLY ranks #1 (60.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
15,509 | $18,601,961 | |
| 2 | ABBV |
AbbVie Inc.
|
23,922 | $6,019,732 | |
| 3 | AZN |
Astrazeneca PLC
|
30,192 | $5,725,007 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,016 | $289,021 | |
| 5 | JNJ |
Johnson & Johnson
|
626 | $158,985 | |
| 6 | PFE |
Pfizer Inc
|
336 | $8,090 | |
| 7 | GRFS |
Grifols SA
|
327 | $2,315 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,601,961 | 15,509 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,313,431 | 1,428 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,622,766 | 1,510 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,152,130 | 1,510 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $734,317 | 942 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $778,007 | 942 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||